GTS Securities’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$550K Sell
6,345
-7,936
-56% -$760K 0.02% 687
2025
Q4
$1.37M Buy
14,281
+7,886
+123% +$766K 0.05% 322
2025
Q3
$609K Buy
6,395
+1,690
+36% +$155K 0.02% 622
2025
Q2
$410K Sell
4,705
-6,979
-60% -$592K 0.02% 749
2025
Q1
$1.05M Buy
11,684
+4,201
+56% +$376K 0.05% 367
2024
Q4
$598K Sell
7,483
-8,857
-54% -$767K 0.03% 530
2024
Q3
$1.47M Sell
16,340
-6,822
-29% -$574K ﹤0.01% 1811
2024
Q2
$1.82M Sell
23,162
-19,752
-46% -$1.62M ﹤0.01% 1576
2024
Q1
$3.74M Sell
42,914
-52,034
-55% -$4.44M 0.01% 1057
2023
Q4
$7.82M Buy
94,948
+20,895
+28% +$1.59M 0.01% 736
2023
Q3
$5.8M Buy
+74,053
New +$6.2M 0.01% 859

Other funds holding MDT

GTS Securities's MDT Position: Q1 2026 in Review

GTS Securities reduced its Medtronic (MDT) stake by 56% in Q1 2026, selling an estimated $760K and leaving 6,345 shares worth $550K. The position accounts for 0.02% of the portfolio, ranked #687.

GTS Securities first reported a position in MDT in Q3 2023 and has held it in 11 quarters since. The position peaked at $7.82M in Q4 2023. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • GTS Securities held 6,345 shares of Medtronic worth $550K as of Q1 2026.
  • GTS Securities sold 7,936 Medtronic shares in Q1 2026, an estimated $760K.
  • Medtronic made up 0.02% of GTS Securities's portfolio in Q1 2026, its #687 holding.
  • GTS Securities first reported a position in Medtronic in Q3 2023 and has held it in 11 quarters since.
  • GTS Securities's Medtronic position peaked at $7.82M in Q4 2023.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.